Title | Date | PubMed ID |
Potent dialkyl substrate-product analogue inhibitors and inactivators of α-methylacyl-coenzyme A racemase from Mycobacterium tuberculosis by rational design. | 2018 Apr | 29502025 |
A study on the AMACR catalysed elimination reaction and its application to inhibitor testing. | 2016 Jan 14 | 26537174 |
Selection of aptamers for fluorescent detection of alpha-methylacyl-CoA racemase by single-bead SELEX. | 2014 Dec 15 | 24994506 |
α-Methylacyl-coenzyme A racemase (AMACR, p504s) is a marker to distinguish malignant melanomas from dysplastic nevi and melanocytic nevi. | 2014 Dec | 25149154 |
The perils of rational design--unexpected irreversible elimination of fluoride from 3-fluoro-2-methylacyl-CoA esters catalysed by α-methylacyl-CoA racemase (AMACR; P504S). | 2014 Nov 25 | 25277991 |
α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC. | 2014 Nov | 25092674 |
Role of AMACR (α-methylacyl-CoA racemase) and MFE-1 (peroxisomal multifunctional enzyme-1) in bile acid synthesis in mice. | 2014 Jul 1 | 24735479 |
Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models. | 2014 | 24712326 |
Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer. | 2013 Oct | 23929631 |
Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomach. | 2012 Aug | 22782380 |